Known or suspected hypersensitivity to -azacitidine or mannitol
Known or suspected hypersensitivity to azacitidine or mannitol
Known hypersensitivity to azacitidine or mannitol
Hypersensitivity to pembrolizumab, azacitidine, mannitol, or any of their excipients
Must not have a known or suspected hypersensitivity to azacitidine, mannitol, or compounds of similar composition to azacitidine
Known allergy or hypersensitivity to azacitidine, mannitol, or midostaurin
Known or suspected hypersensitivity to azacitidine or mannitol
Known or suspected hypersensitivity to azacitidine, mannitol, or durvalumab, its constituents, or to any other humanized monoclonal antibody.
Known or suspected hypersensitivity to azacitidine or mannitol or any other ingredient used in the manufacture of oral azacitidine (see the current azacitidine IB).
Have known or suspected hypersensitivity to azacitidine or any other ingredient used in the manufacturing of Azacitidine.
Has a known hypersensitivity to azacitidine or mannitol
Patients with known allergy to sorafenib or azacitidine, mannitol or any of their components
Participant has a known or suspected hypersensitivity to azacitidine, mannitol, or any other ingredient used in the manufacture of CC- (see the Azacitidine IB).
Known or suspected hypersensitivity to azacitidine or mannitol
Known or suspected hypersensitivity to -azacitidine, romidepsin, mannitol or other agents used in this study
Known hypersensitivity to thalidomide, lenalidomide, azacitidine, or mannitol
Known hypersensitivity to any components of pracinostat, azacitidine, or mannitol
Known or suspected hypersensitivity to azacitidine or mannitol
Known hypersensitivity to azacitidine or mannitol
Known or suspected hypersensitivity to azacitidine or mannitol
Known or suspected hypersensitivity to '-azacitidine or mannitol
Hypersensitivity to azacitidine or mannitol
Known or suspected hypersensitivity to azacitidine or mannitol
Known or suspected hypersensitivity to azacitidine, mannitol, its constituents, or to any other humanized monoclonal antibody
Known or suspected hypersensitivity to azacitidine, pembrolizumab or the excipients of any of the study drugs (including mannitol). Known or suspected hypersensitivity to monoclonal antibodies.
